These results indicate that Bcl-2 expression, tumor size, and cancer-associated lymphohistiocytic inflammation were the 3 significant and independent predictors of the outcome of female cats with ER+ and/or PR+ mammary carcinoma in this cohort. The gene discussed is PGR; the disease is cancer.